Shares of Oklo Inc. climbed 11.3% in pre-market trading to $73.30 on Monday, extending a blistering 31% rally from last Monday's close of $55.88, after a widely circulated Motley Fool report named it a superior bet to rival NuScale Power in the advanced nuclear space. Oklo Surges 31% in One Week as Motley Fool Crowns It the "Cleaner Bet" Over NuScale — But Can a Zero-Revenue Startup Sustain an $11 Billion Valuation?
Shares of Oklo rocketed 11.3% in pre-market to $73.30, capping a 31% weekly rally from $55.88, after a May 25 Motley Fool report declared it the superior pick over rival NuScale Power. The piece called Oklo "the cleaner bet and winner," citing its long runway and high-profile partners including Meta Platforms. For a company that has never booked a dollar of product revenue, the endorsement is doing heavy lifting — and investors should understand exactly what they're buying.
$2.5 Billion in Cash Buys Time, Not Proof
Oklo has a strong balance sheet despite not yet generating revenue from its technology — the company holds $2.5 billion in cash and no debt. That war chest grew dramatically: Oklo ended 2025 with $1.4 billion in cash and marketable securities, then raised an additional $1.182 billion in January 2026 to complete its $1.5 billion stock-sale program.
Full-year 2025 guidance pegged total cash burn at $65–$80 million , meaning the runway stretches roughly a decade at current spending. That cushion is real — but it was built by selling shares, not by selling power.
NuScale's Legal Woes Hand Oklo an Opening The comparison gains extra force because NuScale is wounded. A securities fraud class action was filed alleging NuScale executives misrepresented the capabilities of a key commercialization partner, ENTRA1 Energy, leading to a 12.4% stock drop in November 2025.
The complaint alleges NuScale's administrative expenses ballooned over 3,000% to $519 million in one quarter — largely due to a $495 million payment to that same partner — sending quarterly losses to $532 million.
NuScale's legal issues now make investing in the company "too risky at the moment," per Motley Fool, giving Oklo a narrative advantage by default.
The Market Is Pricing In a Future That Hasn't Arrived
At an $11.5 billion market cap and zero revenue, no regulatory approval, and a large-cap valuation, investors are being asked to pay for a lot of success that simply hasn't happened yet.
Morningstar pegs Oklo's fair value at just $39.34 — meaning the stock trades at a 637% premium to fundamental estimates. Oklo is targeting mid-2026 for early isotope production and claims a pipeline exceeding 14 gigawatts, spanning data centers and defense.
Wall Street Is Split
Bank of America recently initiated coverage with a Buy rating and an $80 price target , while the average 12-month analyst target sits at $89, with estimates ranging from $14 to $140. That $126 spread tells you everything: Oklo is a conviction trade, not a consensus one.